
GLP-1 Weight Loss Drugs Linked to 30% Lower Breast Cancer Risk
A large study of women undergoing breast imaging suggests that GLP-1 medications may reduce the likelihood of developing breast cancer.
Topic
8 stories on health, across Science.

A large study of women undergoing breast imaging suggests that GLP-1 medications may reduce the likelihood of developing breast cancer.

Clinical trial data shows daraxonrasib extends median survival to 13.2 months compared to 6.7 months for chemotherapy in patients with metastatic pancreatic cancer.

Researchers are utilizing artificial intelligence to identify DNA fragment patterns and protein markers in blood to detect lung cancer at earlier, more treatable stages.

Official statistics underrepresent the lung cancer burden in sub-Saharan Africa due to gaps in diagnosis and reporting, researchers warn.

Interim Phase I trial data shows a single dose of a gene-editing treatment significantly reduced LDL cholesterol levels in participants.

A new nasal spray developed by Texas A&M scientists has shown the ability to reduce brain inflammation and restore cognitive function in preclinical models.

New research from the NIH reveals how appetite-controlling brain cells respond to semaglutide, offering insights into why weight loss eventually stalls.

Research indicates that sleeping too little or too much is associated with accelerated biological aging across the brain, heart, lungs, and immune system.